Skip to contentpdufa.bio

LN-145 TIL

Page updated ·next FDA decision on the calendar ·Data as of Nov 19, 2026 12:24 AM ET

LN-145 TIL is an Iovance Biotherapeutics, Inc. program. Its next catalyst is a Readout in Apr 2027.

IOVA catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Iovance Biotherapeutics, Inc. (IOVA). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Apr 2027IOVA

Questions

When is LN-145 TIL's next FDA decision or readout?

The next tracked catalyst for LN-145 TIL is a Readout in Apr 2027.

What happened at LN-145 TIL's most recent FDA decision?

No FDA decision for LN-145 TIL is in our archive yet.

Who makes LN-145 TIL?

Iovance Biotherapeutics, Inc. (IOVA).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings. Each FDA decision links its own page, which names its source or says plainly that it has none.